Author

Margarida Rodrigues

University of CambridgeORCID 0000-0001-6364-7125Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Research Focus:cell-cell communication· 2 Research Focus:differential expression· 2 Approach:experimental assay· 2 Assay:proteomics· 2 Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

David KlenermaniD· 3 shared Clare Elizabeth BryantiD· 2 shared Dilan S. AthaudaiD· 2 shared James R. EvansiD· 2 shared Minee L. ChoiiD· 2 shared Sonia GandhiiD· 2 shared Suman DeiD· 2 shared Aaron Z. WageniD· 1 shared

Activity by Year

2019-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 40 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersNeuroscience

David KlenermanORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

NeuroscienceScience AdvancesPeer-reviewedApr 11, 2025

Astrocytic RNA editing regulates the host immune response to alpha-synuclein

Karishma D’Sa, Minee L. Choi, Aaron Z. Wagen…·Mina Ryten

The paper shows that astrocytic RNA editing via ADAR1 modulates immune responses to alpha-synuclein, contributing to neuroinflammation in Parkinson's disease.

16 citationstop 4%

humanbulk RNA-seq

𝕏 PostBluesky

NeuroscienceNature NeurosciencePeer-reviewedAug 30, 2022

Structural conversion of α-synuclein at the mitochondria induces neuronal toxicity

Minee L. Choi, Alexandre Chappard, Bhanu Singh…·Sonia Gandhi

The paper tracks α-synuclein conformational changes in neurons and shows mitochondrial involvement in oligomerization and toxicity.

258 citationstop 1%

humanproteomics

𝕏 PostBluesky

NeuroscienceActa Neuropathologica CommunicationsPeer-reviewedJul 26, 2019

ADSoluble aggregates present in cerebrospinal fluid change in size and mechanism of toxicity during Alzheimer's disease progression

Suman De, Daniel R. Whiten, Francesco Simone Ruggeri…·David Klenerman

The paper examines soluble Aβ aggregates in CSF from AD, MCI, and healthy controls, finding stage-specific differences in aggregate size and toxicity mechanisms.

98 citationstop 2%

humanproteomics

𝕏 PostBluesky